ESC Premium Access

Anti hypertrophic effects of LCZ696 in chronic cardiac pressure overload

Congress Presentation

About the speaker

Mr Einar Sjaastad Norden

University of Oslo, Oslo (Norway)
0 follower

8 more presentations in this session

Are beta-blockers needed in patients after primary prevention implantable cardioverter-defibrillator? A multicenter population-based cohort study.

Speaker: Professor L. Fauchier (Tours, FR)


Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE

Speaker: Assistant Professor C. Abi Khalil (Doha, QA)


Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry

Speaker: Professor J. De Sutter (Ghent, BE)


Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure

Speaker: Doctor R. Wurm (Vienna, AT)


Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure

Speaker: Associate Professor T. Ichiki (Rochester, US)


Access the full session

Drug therapy of heart failure

Speakers: Mr E. Sjaastad Norden, Professor L. Fauchier, Assistant Professor C. Abi Khalil, Professor J. De Sutter, Doctor R. Wurm...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb